1. Targeting tumor vascularization: promising strategies for vascular normalization
   Ruiqi Zheng et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
2. A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
   Jie Wang et al, 2022, Frontiers in Immunology CrossRef
3. Mechanisms of angiogenesis in tumour
   Run Zhang et al, 2024, Frontiers in Oncology CrossRef
4. Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs
   Aparna Maiti et al, 2021, Cancers CrossRef
5. The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
   Lin He et al, 2021, Cancers CrossRef
6. Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs
   Snehal Nimal et al, 2024, Scientific Reports CrossRef
7. Epigenetic regulation and therapeutic targets in the tumor microenvironment
   Zhuojun Xie et al, 2023, Molecular Biomedicine CrossRef
8. Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms
   Lichuan Wu et al, 2021, Marine Drugs CrossRef
9. A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway
   Ying Han et al, 2022, Molecules CrossRef
10. Research Progress of HDACs Family in Breast Cancer
    豪芳 苑, 2023, Advances in Clinical Medicine CrossRef
11. Vasculogenic mimicry
    E.Z. Lapkina et al, 2023, Arkhiv patologii CrossRef
12. Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer
    Ahmad Salahuddin et al, 2022, Medical Oncology CrossRef
13. Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer
    Xin-Chen Jiang et al, 2022, Journal of Medicinal Chemistry CrossRef
14. Recent advancement of HDAC inhibitors against breast cancer
    Syed Abdulla Mehmood et al, 2023, Medical Oncology CrossRef
15. Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats
    Yifeng Luo et al, 2021, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
16. HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
    Cristina Maccallini et al, 2022, Pharmaceuticals CrossRef
17. A glimpse into novel acylations and their emerging role in regulating cancer metastasis
    Huifang Shi et al, 2024, Cellular and Molecular Life Sciences CrossRef
18. Phenotypic Transitions the Processes Involved in Regulation of Growth and Proangiogenic Properties of Stem Cells, Cancer Stem Cells and Circulating Tumor Cells
    Magdalena Kulus et al, 2024, Stem Cell Reviews and Reports CrossRef
19. Alternative Vascularization Mechanisms in Tumor Resistance to Therapy
    Dorina Belotti et al, 2021, Cancers CrossRef
20. Structure-Based Design of a Selective Class I Histone Deacetylase (HDAC) Near-Infrared (NIR) Probe for Epigenetic Regulation Detection in Triple-Negative Breast Cancer (TNBC)
    Kuojun Zhang et al, 2021, Journal of Medicinal Chemistry CrossRef
21. Insight into Structure-Activity Relationship of New Compounds for Breast Cancer Treatment
    Lu Li et al, 2023, Current Topics in Medicinal Chemistry CrossRef
22. Investigational Drug Treatments for Triple-Negative Breast Cancer
    Christos Damaskos et al, 2021, Journal of Personalized Medicine CrossRef
23. Integrated Analysis Reveals the Potential Significance of HDAC Family Genes in Lung Adenocarcinoma
    Congkuan Song et al, 2022, Frontiers in Genetics CrossRef